Sonoma Pharmaceuticals, Inc. NASDAQ:SNOA

Sonoma Pharmaceuticals stock price today

$5.22
+2.46
+89.82%
Financial Health
0
1
2
3
4
5
6
7
8
9

Sonoma Pharmaceuticals stock price monthly change

+640.24%
month

Sonoma Pharmaceuticals stock price quarterly change

+640.24%
quarter

Sonoma Pharmaceuticals stock price yearly change

+1361.99%
year

Sonoma Pharmaceuticals key metrics

Market Cap
3.43M
Enterprise value
834.72K
P/E
-0.42
EV/Sales
0.06
EV/EBITDA
-0.12
Price/Sales
0.23
Price/Book
0.53
PEG ratio
-0.16
EPS
-1.76
Revenue
11.65M
EBITDA
-7.13M
Income
-6.26M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
-54.05%
Oper. margin
-51.61%
Gross margin
29.54%
EBIT margin
-51.61%
EBITDA margin
-61.24%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Sonoma Pharmaceuticals stock price history

Sonoma Pharmaceuticals stock forecast

Sonoma Pharmaceuticals financial statements

Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA): Profit margin
Dec 2021 2.90M -944K -32.53%
Mar 2022 2.29M -2.94M -128.11%
Mar 2023 3.01M -1.30M -43.4%
Mar 2024 3.43M -1.06M -31.03%
Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA): Analyst Estimates
Sep 2025 5.24M -545.45K -10.41%
Oct 2025 5.01M -312.14K -6.23%
Dec 2025 5.42M -156.07K -2.88%
Mar 2026 6M -109.09K -1.82%
  • Analysts Price target

  • Financials & Ratios estimates

Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA): Debt to assets
Sep 2022 14962000 7.94M 53.07%
Dec 2022 13928000 8.36M 60.09%
Mar 2023 16231000 8.25M 50.85%
Mar 2024 14893000 8.75M 58.79%
Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA): Cash Flow
Dec 2021 -326K -49K 463K
Mar 2022 -1.39M -61K 222K
Mar 2023 -2.44M -82K 3.37M
Mar 2024 152K 18K 622K

Sonoma Pharmaceuticals alternative data

Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA): Employee count
Aug 2023 9
Sep 2023 9
Oct 2023 9
Nov 2023 9
Dec 2023 9
Jan 2024 9
Feb 2024 9
Mar 2024 9
Apr 2024 9
May 2024 9
Jun 2024 9
Jul 2024 10

Sonoma Pharmaceuticals other data

100.00% 0.00%
of SNOA is owned by hedge funds
84.37K -58.06K
shares is hold by hedge funds

Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA): Insider trades (number of shares)
Period Buy Sel
Aug 2017 3793 0
Nov 2017 4789 0
Mar 2018 7273 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
MILLER ROBERT E other: Former CFO
Common Stock, $0.0001 par value per share 1,200 N/A N/A
Purchase
MILLER ROBERT E other: Former CFO
Common Stock, $0.0001 par value per share 1,200 N/A N/A
Purchase
MILLER ROBERT E other: Former CFO
Common Stock, $0.0001 par vlue per share 1,200 N/A N/A
Purchase
MILLER ROBERT E other: Former CFO
Common Stock, $0.0001 par vlue per share 1,200 N/A N/A
Purchase
SCHUTZ JAMES J other: Former CEO and Former Di..
Common Stock, $0.0001 par value per share 2,473 N/A N/A
Purchase
SCHUTZ JAMES J other: Former CEO and Former Di..
Common Stock, $0.0001 par value per share 345 N/A N/A
Purchase
MILLER ROBERT E other: Former CFO
Common Stock, $0.0001 par value per share 1,790 N/A N/A
Purchase
SCHUTZ JAMES J other: Former CEO and Former Di..
Common Stock, $0.0001 par value per share 400 N/A N/A
Purchase
SCHUTZ JAMES J other: Former CEO and Former Di..
Common Stock, $0.0001 par value per share 254 N/A N/A
Purchase
MILLER ROBERT E other: Former CFO
Common Stock, $0.0001 par value per share 2,000 N/A N/A
Thursday, 5 December 2024
accesswire.com
Wednesday, 27 November 2024
zacks.com
Thursday, 21 November 2024
accesswire.com
Monday, 11 November 2024
accesswire.com
Thursday, 7 November 2024
accesswire.com
Thursday, 31 October 2024
accesswire.com
Tuesday, 22 October 2024
accesswire.com
Thursday, 19 September 2024
accesswire.com
Tuesday, 17 September 2024
accesswire.com
Wednesday, 11 September 2024
accesswire.com
Wednesday, 28 August 2024
accesswire.com
Monday, 26 August 2024
accesswire.com
Wednesday, 21 August 2024
accesswire.com
Thursday, 8 August 2024
accesswire.com
Monday, 15 July 2024
zacks.com
Tuesday, 9 July 2024
accesswire.com
Friday, 28 June 2024
zacks.com
Monday, 17 June 2024
accesswire.com
Thursday, 9 May 2024
accesswire.com
Tuesday, 9 April 2024
accesswire.com
Thursday, 4 April 2024
accesswire.com
Thursday, 28 March 2024
Accesswire
Friday, 9 June 2023
Investopedia
Investopedia
Thursday, 2 March 2023
PennyStocks
Tuesday, 31 January 2023
PennyStocks
Thursday, 26 January 2023
PennyStocks
Wednesday, 25 January 2023
InvestorPlace
Thursday, 3 November 2022
PennyStocks
Tuesday, 3 May 2022
InvestorPlace
  • What's the price of Sonoma Pharmaceuticals stock today?

    One share of Sonoma Pharmaceuticals stock can currently be purchased for approximately $5.22.

  • When is Sonoma Pharmaceuticals's next earnings date?

    Unfortunately, Sonoma Pharmaceuticals's (SNOA) next earnings date is currently unknown.

  • Does Sonoma Pharmaceuticals pay dividends?

    No, Sonoma Pharmaceuticals does not pay dividends.

  • How much money does Sonoma Pharmaceuticals make?

    Sonoma Pharmaceuticals has a market capitalization of 3.43M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 4.05% to 12.74M US dollars.

  • What is Sonoma Pharmaceuticals's stock symbol?

    Sonoma Pharmaceuticals, Inc. is traded on the NASDAQ under the ticker symbol "SNOA".

  • What is Sonoma Pharmaceuticals's primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.

  • How do i buy shares of Sonoma Pharmaceuticals?

    Shares of Sonoma Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Sonoma Pharmaceuticals's key executives?

    Sonoma Pharmaceuticals's management team includes the following people:

    • Ms. Amy M. Trombly Chief Executive Officer & Pres(age: 57, pay: $428,000)
    • Mr. Bruce Thornton Chief Operating Officer & Corporation Sec.(age: 61, pay: $365,000)
    • Mr. Jerome Dvonch Chief Financial Officer(age: 56, pay: $221,910)
  • How many employees does Sonoma Pharmaceuticals have?

    As Jul 2024, Sonoma Pharmaceuticals employs 10 workers, which is 11% more then previous month and 11% more then previous quarter.

  • When Sonoma Pharmaceuticals went public?

    Sonoma Pharmaceuticals, Inc. is publicly traded company for more then 18 years since IPO on 25 Jan 2007.

  • What is Sonoma Pharmaceuticals's official website?

    The official website for Sonoma Pharmaceuticals is sonomapharma.com.

  • Where are Sonoma Pharmaceuticals's headquarters?

    Sonoma Pharmaceuticals is headquartered at 645 Molly Lane, Woodstock, GA.

  • How can i contact Sonoma Pharmaceuticals?

    Sonoma Pharmaceuticals's mailing address is 645 Molly Lane, Woodstock, GA and company can be reached via phone at +800 7599305.

Sonoma Pharmaceuticals company profile:

Sonoma Pharmaceuticals, Inc.

sonomapharma.com
Exchange:

NASDAQ

Full time employees:

10

Industry:

Drug Manufacturers - Specialty & Generic

Sector:

Healthcare

Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription product to manage and relieve burning, itching, and pain experienced with various types of dermatoses; Celacyn gel, a HOCl-based topical prescription product indicated to promote efficient healing through the management of new and old scars; and SebuDerm to manage and relieve the burning, itching, erythema, scaling, and pain associated with seborrhea and seborrheic dermatitis. It also provides Acuicyn, a HOCl-based product indicated to relieve itch and inflammation while helping to keep areas around the eye clean; and Microcyn, a HOCl-based topical line of products designed to stimulate expedited healing by targeting a wide range of pathogens, as well as antibiotic-resistant strains that slow the natural healing of wounds. In addition, the company offers MicrocynAH, an HOCl-based solution designed to relieve common symptoms of hot spots, scratches, skin rashes post-surgical sites, and irritated animal skin for healing; Microdacyn60 oral care solution for the treatment of mouth and throat infections; MucoClyns for the use in emergencies and safe to use on mucous membranes, cuts, abrasions, burns, and body surfaces; Endocyn root canal irrigation solutions; Pediacyn atopic dermatitis hydrogel; Ocucyn eyelid and eyelash cleanser; Gramaderm for the treatment of topical mild to moderate acne; Nanocyn, a hospital-grade disinfectant; and Sinudox for nasal irrigation. The company was formerly known as Oculus Innovative Sciences, Inc. and changed its name to Sonoma Pharmaceuticals, Inc. in December 2016. Sonoma Pharmaceuticals, Inc. was incorporated in 1999 and is based in Woodstock, Georgia.

645 Molly Lane
Woodstock, GA 30189

CIK: 0001367083
ISIN: US83558L2043
CUSIP: 83558L204